DV
Dividend Vision

OMER — Omeros Corporation

Omeros Corporation (OMER)

Total return is 96.9% over the past 16.8 years, 784.1 points behind SPY at 881.0%. Its deepest 1-year drawdown was 49.5%.

This is a single-stock equity holding in Omeros Corporation, a biopharmaceutical company, rather than a diversified ETF. As a concentrated stock position, it does not generate dividend distributions and carries no expense ratio data typical of fund structures. This holding appeals primarily to investors seeking direct exposure to a specific pharmaceutical company rather than those pursuing broad dividend income or passive diversified strategies.

OMER key facts

Asset type
Stock
Asset class
Equity
Inception date
10/08/2009
Distribution frequency
None
Last close
$17.19
Market cap
$1,244,132,352
Average volume
3673800.0
Beta
2.538
Payout ratio
0.0
P/E ratio
10.4182
Forward P/E
58.1395
EPS
$1.65